183 related articles for article (PubMed ID: 33609743)
1. Tumor cell-targeting radiotherapy in the treatment of glioblastoma multiforme using linear accelerators.
Chiang CS; Shih IJ; Shueng PW; Kao M; Zhang LW; Chen SF; Chen MH; Liu TY
Acta Biomater; 2021 Apr; 125():300-311. PubMed ID: 33609743
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme.
Choi J; Kim G; Cho SB; Im HJ
J Nanobiotechnology; 2020 Sep; 18(1):122. PubMed ID: 32883290
[TBL] [Abstract][Full Text] [Related]
3. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
5. Role of radiation therapy and radiosurgery in glioblastoma multiforme.
Fiveash JB; Spencer SA
Cancer J; 2003; 9(3):222-9. PubMed ID: 12952307
[TBL] [Abstract][Full Text] [Related]
6. CD44-associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage.
Liu WH; Lin JC; Chou YC; Li MH; Tsai JT
Cancer Med; 2020 Jan; 9(1):350-360. PubMed ID: 31746135
[TBL] [Abstract][Full Text] [Related]
7. Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization.
Joh DY; Sun L; Stangl M; Al Zaki A; Murty S; Santoiemma PP; Davis JJ; Baumann BC; Alonso-Basanta M; Bhang D; Kao GD; Tsourkas A; Dorsey JF
PLoS One; 2013; 8(4):e62425. PubMed ID: 23638079
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitization with Gadolinium Chelate-Coated Gold Nanoparticles Prevents Aggressiveness and Invasiveness in Glioblastoma.
Durand M; Chateau A; Jubréaux J; Devy J; Paquot H; Laurent G; Bazzi R; Roux S; Richet N; Reinhard-Ruch A; Chastagner P; Pinel S
Int J Nanomedicine; 2023; 18():243-261. PubMed ID: 36660336
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
Chang JE; Khuntia D; Robins HI; Mehta MP
Clin Adv Hematol Oncol; 2007 Nov; 5(11):894-902, 907-15. PubMed ID: 18185489
[TBL] [Abstract][Full Text] [Related]
10. ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma.
Pepper NB; Eich HT; Müther M; Oertel M; Rehn S; Spille DC; Stummer W
Radiat Oncol; 2024 Jan; 19(1):11. PubMed ID: 38254201
[TBL] [Abstract][Full Text] [Related]
11. Megavoltage Radiosensitization of Gold Nanoparticles on a Glioblastoma Cancer Cell Line Using a Clinical Platform.
Kazmi F; Vallis KA; Vellayappan BA; Bandla A; Yukun D; Carlisle R
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936587
[TBL] [Abstract][Full Text] [Related]
12. Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme.
Nieder C; Nestle U; Ketter R; Kolles H; Gentner SJ; Steudel WI; Schnabel K
Radiat Oncol Investig; 1999; 7(1):36-41. PubMed ID: 10030622
[TBL] [Abstract][Full Text] [Related]
13. Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential.
Hopewell JW; Gorlia T; Pellettieri L; Giusti V; H-Stenstam B; Sköld K
Appl Radiat Isot; 2011 Dec; 69(12):1737-40. PubMed ID: 21482122
[TBL] [Abstract][Full Text] [Related]
14. Novel Strategies for Nanoparticle-Based Radiosensitization in Glioblastoma.
Ruiz-Garcia H; Ramirez-Loera C; Malouff TD; Seneviratne DS; Palmer JD; Trifiletti DM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575840
[TBL] [Abstract][Full Text] [Related]
15. Theranostic nanoparticles enhance the response of glioblastomas to radiation.
Wu W; Klockow JL; Mohanty S; Ku KS; Aghighi M; Melemenidis S; Chen Z; Li K; Morais GR; Zhao N; Schlegel J; Graves EE; Rao J; Loadman PM; Falconer RA; Mukherjee S; Chin FT; Daldrup-Link HE
Nanotheranostics; 2019; 3(4):299-310. PubMed ID: 31723547
[TBL] [Abstract][Full Text] [Related]
16. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
17. Boron neutron capture therapy for glioblastoma multiforme.
van Rij CM; Wilhelm AJ; Sauerwein WA; van Loenen AC
Pharm World Sci; 2005 Apr; 27(2):92-5. PubMed ID: 15999918
[TBL] [Abstract][Full Text] [Related]
18. An investigation of boron neutron capture therapy for recurrent glioblastoma multiforme.
Pellettieri L; H-Stenstam B; Rezaei A; Giusti V; Sköld K
Acta Neurol Scand; 2008 Mar; 117(3):191-7. PubMed ID: 18297764
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.
Floyd NS; Woo SY; Teh BS; Prado C; Mai WY; Trask T; Gildenberg PL; Holoye P; Augspurger ME; Carpenter LS; Lu HH; Chiu JK; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):721-6. PubMed ID: 14967426
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial to determine the safety, pharmacodynamics, and pharmacokinetics of RSR13, a novel radioenhancer, in newly diagnosed glioblastoma multiforme.
Kleinberg L; Grossman SA; Piantadosi S; Pearlman J; Engelhard H; Lesser G; Ruffer J; Gerber M
J Clin Oncol; 1999 Aug; 17(8):2593-603. PubMed ID: 10561327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]